Clark & Elbing LLP
Enhanced ATRA-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions
The invention features all-trans retinoic acid (ATRA)-related compounds capable of associating with Pin1 and methods of treating a proliferative disorder characterized by elevated Pin1 marker levels, Pin1 degradation, and/or reduced Pin1 Ser71 phosphorylation in a subject by administering an ATRA-related compound. The invention also features methods of treating proliferative disorders, autoimmune diseases, and addiction conditions (e.g., diseases, disorders, and conditions characterized by elevated Pin1 marker levels) by administering an ATRA-related compound in combination with another therapeutic compound.
Beth Israel Deaconess Medical Center, Inc.
A A A A A A A A A A A A A A A A A A Y
A61K A61K A61K A61K A61K A61K A61K A61K A61K A61K A61K A61K A61K A61K A61K A61K A61K A61K Y02A
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional
Michelle Lynn Lijun Xiao Zhen Kun Ping Shuo
Hall Sun Zhou Lu Wei